Bird flu cases in the US and Australia spark a surge in vaccine stocks. The discoveries, including a mild case in Michigan and Australia’s first, raise concerns about potential human-to-human transmission and the need for further research.
Following two reports of human bird flu infections—one in the US and the other in Australia—shares of vaccine makers saw a sharp rise on Wednesday. The growing possibility of human-to-human transmission, which is still unknown, is being closely watched by the federal authorities.
The Michigan Department of Health and Human Services announced on Wednesday that a farmworker who was exposed to a lot of sick livestock experienced mild symptoms but is now well.
“The current health risk to the general public remains low,” Dr. Natasha Bagdasarian, Michigan’s chief medical executive, said in a news release. “
Bagdasarian continued, “We have not seen signs of sustained human-to-human transmission at this point. This is exactly how public health is meant to work, in early detection and monitoring of new and emerging illnesses.”
The second instance was recorded in Victoria, a state in southeast Australia. This is the nation’s first incidence of avian flu in humans.
The H5N1 form of avian flu has been ravaging the planet for a few years, killing hundreds of millions of wild and farmed birds, if not more. There seems to be a virus evolution that is infecting people.
Yesterday evening, Goldman analysts noted that there were “green shoots across Vax Names following reports of human bird-flu infections confirmed in the US and Australia.” They reported that vaccine firms saw increases of 14%, 11%, +18%, and 5.3% for Moderna, BioNTech, and CureVac.
Business headlines about “bird flu” started to appear in late March.
Every month, the headlines about “bird flu” in the corporate media have reached all-time highs. Before elections, dread must be spread.
Dr. Robert Redfield, the former director of the CDC, cautioned NewsNation this week:
“That’s the real biosecurity threat that these university labs are doing bio-experiments that are intentionally modifying viruses – and I think bird flu is going to be the cause of the Great Pandemic – where they’re teaching these viruses to be more infectious for humans.”
Maybe the best course of action is to put an end to “gain-of-function” research out of concern for the welfare of all people before overeducated Ivy League fools accidentally trigger the next major epidemic.
As recently reported by GreatGameIndia, Dr. Robert Califf, Commissioner of the FDA, stated that they are preparing for the possible spread of bird flu among humans, with one verified case already reported in Texas this year.
